Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort

被引:7
作者
Lammi, Matthew R. [1 ]
Saketkoo, Lesley A. [2 ]
Gordon, Jessica K. [3 ]
Lauto, Paula [1 ]
Fagan, Karen [4 ]
Steen, Virginia D. [5 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Pulm Crit Care & Allergy Immunol, New Orleans, LA USA
[2] Tulane Univ, Sch Med, Sect Pulm Dis Crit Care & Environm Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[3] Hosp Special Surg, Dept Rheumatol, 535 E 70th St, New York, NY 10021 USA
[4] Univ S Alabama, Pulm & Crit Care, Mobile, AL USA
[5] Georgetown Univ, Div Rheumatol, Washington, DC USA
基金
美国国家卫生研究院;
关键词
diastolic dysfunction; pulmonary hypertension; scleroderma; systemic sclerosis; treatment; 6-MINUTE WALK TEST; VENTRICULAR DIASTOLIC DYSFUNCTION; HEART-FAILURE; OUTCOMES; RECOGNITION; PREVALENCE; PROGNOSIS; GRADIENT; DISEASE; MARKER;
D O I
10.1111/resp.13067
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective: Systemic sclerosis (SSc) is a complex autoimmune disease commonly associated with pulmonary hypertension (PH). When associated with elevated pulmonary artery wedge pressure (PAWP), pulmonary artery pressure (PAP) is either inproportion (post-capillary PH) or higher than expected (combined PH) relative to the increased PAWP. Methods: Patients from the PHAROS registry (a prospective observational cohort of SSc-PH patients) who had mean PAP >= 25 and PAWP > 15 on right heart catheterization were stratified based on diastolic pressure gradient (DPG). Kaplan-Meier analysis was performed to compare survival and PH-related hospitalization. Baseline factors were compared between patients dying and those who survived using Cox regression analysis. Results: A total of 59 patients were included, of whom 21 (36%) patients were classified as combined PH and 38 (64%) had post-capillary PH. No baseline characteristics were significantly different between the two groups. There were no differences in survival or PHrelated hospitalization between the groups. The only baseline factor independently associated with death was lower 6-min walk distance (6MWD) (hazard ratio (HR): 1.33 per 25 m decrease, 95% CI: 1.11-1.59, P = 0.002). PH-specific medications were started during follow-up in significantly more patients in the combined PH group compared with the post-capillary group (86% vs 50%, P = 0.01). Conclusion: Outcomes were similar between SSc patients with post-capillary PH and combined pre- and post-capillary PH. 6MWD at baseline can predict risk for death in SSc patients with PH and an elevated PAWP. More patients with combined PH were started on PH-specific medications, and the clinical benefit of treating this subgroup specifically in SSc patients needs further exploration.
引用
收藏
页码:1386 / 1392
页数:7
相关论文
共 50 条
  • [41] Pulmonary hypertension in Spanish patients with systemic sclerosis. Data from the RESCLE registry
    Francisco J. García-Hernández
    María J. Castillo-Palma
    Carles Tolosa-Vilella
    Alfredo Guillén-del Castillo
    Manuel Rubio-Rivas
    Mayka Freire
    José A. Vargas-Hitos
    José A. Todolí-Parra
    Mónica Rodríguez-Carballeira
    Gerard Espinosa-Garriga
    Dolores Colunga-Argüelles
    Norberto Ortego-Centeno
    Luis Trapiella-Martínez
    María M. Rodero-Roldán
    Xavier Pla-Salas
    Isabel Perales-Fraile
    Isaac Pons-Martín del Campo
    Antonio J. Chamorro
    Rafael A. Fernández-de la Puebla Giménez
    Ana B. Madroñero-Vuelta
    Manuel Ruíz-Muñoz
    Vicent Fonollosa-Pla
    Carmen P. Simeón-Aznar
    Clinical Rheumatology, 2019, 38 : 1117 - 1124
  • [42] Comprehensive description of the prevalence, serological and clinical characteristics, and visceral involvement of systemic sclerosis (scleroderma) in a large cohort from the United Arab Emirates Systemic Sclerosis Registry
    Namas, Rajaie
    Elarabi, Mohamed
    Khan, Saniya
    Mubashir, Asia
    Memisoglu, Esat
    El-Kaissi, Mahmoud
    Joshi, Abhay
    Chapman, Jeffrey
    Jassim, Imad
    Khogali, Hiba
    Hassan, Nada
    Sabbour, Hani
    Saleh, Khaled
    Alnaqbi, Khalid A.
    Zayat, Ahmed S.
    Diab, Sehriban
    Awir, Zyiad
    Abu Taha, Nehad
    Ginawi, Amel
    Al Ansari, Atheer
    Rifaai, Hazem
    Alrawi, Zaid
    Al Dhaheri, Afra
    Ibrahim, Gamal
    Abogamal, Ahmed
    Al Shehhi, Waleed
    Teir, Jamal
    Khan, Tahir
    Musgrave, Maisam
    Hameed, Beena
    Khan, Bhavna
    Mosallam, Nagwa
    Hussien, Nahla
    Hussein, Iman
    Abdulelhamid, Abeer
    Ali, Ahmed
    Hannawi, Suad
    Al Izzi, Mustafa
    Badsha, Humeira
    Al Saleh, Jamal
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2023, 8 (02) : 137 - 150
  • [43] Contribution of the left atrial remodeling to the elevated pulmonary capillary wedge pressure in patients with WHO Group II pulmonary hypertension
    Purga, Scott L.
    Karas, Maria G.
    Horn, Evelyn M.
    Torosoff, Mikhail T.
    JOURNAL OF ECHOCARDIOGRAPHY, 2019, 17 (04) : 187 - 196
  • [44] Exercise Echocardiography Predicts Future Development of Pulmonary Hypertension in a High-risk Cohort of Patients with Systemic Sclerosis
    Quinn, Kaitlin A.
    Wappel, Stephanie R.
    Kuru, Tunay
    Steen, Virginia D.
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (05) : 708 - 713
  • [45] Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study
    Vasiliki-Kalliopi Bournia
    Anastasios Kallianos
    Stylianos Panopoulos
    Elias Gialafos
    Lemonia Velentza
    Panayiotis G. Vlachoyiannopoulos
    Petros P. Sfikakis
    Georgia Trakada
    Rheumatology International, 2022, 42 : 303 - 309
  • [46] Pulmonary hypertension in systemic lupus erythematosus: Clinical association and survival in 18 patients
    Li, EK
    Tam, LS
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (09) : 1923 - 1929
  • [47] Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study
    Bournia, Vasiliki-Kalliopi
    Kallianos, Anastasios
    Panopoulos, Stylianos
    Gialafos, Elias
    Velentza, Lemonia
    Vlachoyiannopoulos, Panayiotis G.
    Sfikakis, Petros P.
    Trakada, Georgia
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (02) : 303 - 309
  • [48] Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: a nationwide cohort study
    Chen, Hung-An
    Hsu, Tsai-Ching
    Yang, Su-Ching
    Weng, Chia-Tse
    Wu, Chun-Hsin
    Sun, Chien-Yao
    Lin, Chun-Yu
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [49] Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients
    Cacciapaglia, Fabio
    Airo, Paolo
    Fornaro, Marco
    Trerotoli, Paolo
    De Lorenzis, Enrico
    Corrado, Addolorata
    Lazzaroni, Maria Grazia
    Natalello, Gerlando
    Montini, Fabio
    Altomare, Alberto
    Urso, Livio
    Verardi, Lucrezia
    Bosello, Silvia Laura
    Cantatore, Francesco Paolo
    Iannone, Florenzo
    RHEUMATOLOGY, 2023, 62 (04) : 1552 - 1558
  • [50] Hypochromic erythrocytes as prognostic indicator of survival among patients with systemic sclerosis screened for pulmonary hypertension
    Gordjani, O.
    Xanthouli, P.
    Eichstadt, C.
    Benjamin, N.
    Egenlauf, B.
    Harutyunova, S.
    Marra, A.
    Theobald, V
    Milde, N.
    Nagel, C.
    Blank, N.
    Lorenz, H.
    Gruenig, E.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60